Based on the provided documents, here's a breakdown of the vulnerability described in CVE-2023-38575:

**Root Cause of Vulnerability:**
The vulnerability stems from the "non-transparent sharing of return predictor targets between contexts" within certain Intel processors. This means that the processor's return predictor, which is used to optimize function returns, is not properly isolated between different contexts (e.g., different processes or virtual machines).

**Weaknesses/Vulnerabilities Present:**
- **Non-transparent sharing:** The core issue is the lack of proper isolation in the return predictor.
- **Microarchitectural vulnerability:** The vulnerability resides within the microarchitectural design of the affected Intel processors.

**Impact of Exploitation:**
- **Information Disclosure:** An attacker can potentially exploit this vulnerability to gain access to sensitive information. This is achieved by observing or influencing the return predictor behavior in a way that leaks data from other contexts.

**Attack Vectors:**
- **Local Access:** The vulnerability requires the attacker to have local access to the system running the affected processor. This implies that the attacker must be able to execute code on the target machine.

**Required Attacker Capabilities/Position:**
- **Authorized User:** The attacker needs to be an authorized user with the ability to execute code on the system.
- **Local access:** The attacker needs to be running locally on the target machine.
- **No UI interaction required:**  The attack can be carried out without requiring any interaction from the user.

**Additional Notes:**
- The vulnerability is classified as **Medium** severity.
- Intel has released microcode updates to mitigate this vulnerability.
- The vulnerability is addressed by firmware updates provided by system manufacturers.
- For Intel SGX enabled systems, the microcode patch needs to be loaded in platform flash designated by the firmware interface table (FIT) entry point 1 to be fully effective
- NetApp has identified products that are not affected, with certain products still under investigation.